PENTAX of America, Inc.
Pharmaceutical & medical device company payment data from CMS Open Payments.
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $3.9M | 246 | 57.1% |
| Gift | $969,185 | 119 | 14.2% |
| Consulting Fee | $780,942 | 233 | 11.4% |
| Grant | $360,741 | 37 | 5.3% |
| Long term medical supply or device loan | $248,737 | 346 | 3.6% |
| Space rental or facility fees (teaching hospital only) | $210,549 | 41 | 3.1% |
| Travel and Lodging | $185,882 | 124 | 2.7% |
| Food and Beverage | $139,933 | 2,662 | 2.1% |
| Honoraria | $23,451 | 12 | 0.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $3,240 | 2 | 0.0% |
| Charitable Contribution | $2,500 | 1 | 0.0% |
| Entertainment | $1,477 | 13 | 0.0% |
| Education | $700.00 | 1 | 0.0% |
Payments by Type
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| FDA post market Sampling and Culturing Study (FDA 522- PS15004/PS002) | $1.0M | 0 | 4 |
| Multi-center Clinical Study to Evaluate the C2 CryoBalloon Focal Ablation System for the Treatment of Patients With Previously Untreated Dysplastic Barrett's Epithelium | $748,330 | 0 | 51 |
| Coldplay 3: Multi-Center Clinical Study to Evaluate the Coldplay CryoBalloonTM Focal Ablation System for the Treatment of Patients with Previously- Untreated Dysplastic Barrett's Epithelium | $617,778 | 0 | 60 |
| Duodenoscope 522 Postmarket Surveillance Study | $220,241 | 0 | 25 |
| Nitrous Oxide For Endoscopic Ablation of Refractory Barrett's Esophagus (NO FEAR-BE) | $188,554 | 0 | 2 |
| Evaluation of CryoBalloon Focal Ablation System in patients with Barrett's Esophagus (Coldplay 2) | $187,912 | 0 | 3 |
| Nitrous Oxide For Endoscopic Ablation or Refractory Barrett's Esophagus | $130,750 | 0 | 2 |
| Nitrous Oxide CryoBalloon Ablation forEradication of Non-Ampullary Sporadic and Familial Duodenal Adenomas | $83,793 | 0 | 3 |
| COLDPLAY 3: Multi-Center Clinical Study to Evaluate the Coldplay Cryoballoon Focal Ablation System for the Treatment of Patients with Previously Untreated Dysplastic Barrett's Epithelium | $78,802 | 0 | 2 |
| Multi-Center Clinical Study to Evaluate the Coldplay CryoballoonTM Focal Ablation System for the Treatment of Patients with Previously Untreated Dysplastic Barrett's Epithelium (Coldplay 3) | $70,249 | 0 | 9 |
| Coldplay 3 | $62,510 | 0 | 4 |
| Evaluating the Intraoperative Use of I-Scan in the Diagnosis and Treatment of Laryngeal Lesions | $58,617 | 0 | 2 |
| Coldplay 3: Multicenter Clinical Study to Evaluate the C2 CryoBalloon Focal Ablation System for the Treatment of Patients with Previously Untreated Dysplastic Barrett's Epithelium | $55,923 | 0 | 26 |
| Coldplay 3: Multicenter Clinical Study to Evaluate the CryoBalloonTM Focal Ablation System for the Treatment of Patients with Previosuly-Untreated Dysplastic Barrett's Epithelium | $49,593 | 0 | 8 |
| Pilot Study of Nitrous Oxide Cryoballoon Ablation for Eradication of Non-Ampullary Sporadic and Familial Duodenal Adenomas | $40,000 | 0 | 1 |
| FDA 522 Postmarket Surveillance Study | $39,961 | 0 | 3 |
| Nitrous Oxide for Endoscopic Ablation of Refractory Barrett's Esophagus | $22,934 | 0 | 1 |
| Clinical Study to Evaluate the Coldplay CryoBalloonTM Full and Swipe Ablation Systems for the Ablation of Human Esophageal Epithelium | $21,270 | 0 | 1 |
| 522 Study Site - Admin Start Up Fee | $20,400 | 0 | 1 |
| Prospective Characterization of the Neo-Squamous Epithelial Barrier Following Successful Endoscopic Therapy in Barrett's Esophagus | $19,500 | 0 | 1 |
| CryoBalloon Ablation for Treatment of Duodenal Adenomas (C2D2) | $16,990 | 0 | 9 |
| Prognostic value of red density in Ulcerative Colitis: Proceed - UC Study | $15,003 | 0 | 1 |
| Multi-Center Clinical Study to Evaluate the C2 CryoBalloon Focal Ablation System for the Treatment of Patients With Previously Untreated Dysplastic Barrett's Epithelium | $13,119 | 0 | 1 |
| Multi-Center Clinical Study to Evaluate the Coldplay CryoBalloonTM Focal Ablation System for the Treatment of Patients with Previously Untreated Dysplastic Barretts Epithelium (Coldplay 3) | $12,660 | 0 | 2 |
| 522 Postmarket Surveillance Study | $12,600 | 0 | 2 |
| Multi-Center Clinical Study to Evaluate the Coldplay CryoballoonTM Focal Ablation System for the Treatment of Patients with Previously Untreated Dysplastic Barrett's Epithelium (COLDPLAY 3) | $11,378 | 0 | 3 |
| Coldplay 3: Multi-Center Clinical Study to Evaluate the Coldplay CryoballoonTM Focal Ablation System for the Treatment of Patients with Previously Untreated Dysplastic Barrett's Epithelium | $8,750 | 0 | 1 |
| Coldplay 3: Multi-Center Clinical Study to Evaluate the Coldplay CryoBalloonTM Focal Ablation System for the Treatment of Patients with Previously-Untreated Dysplastic Barrett's Epithelium | $8,000 | 0 | 1 |
| Coldplay 3: Multi-Center Clinical Study to Evaluate the Coldplay CryoBalloonTM Focal Ablation System for the Treatment of Patients with Previosuly-Untreated Dysplastic Barrett's Epithelium | $7,251 | 0 | 4 |
| Safety and Efficacy of the Cryoballoon Ablation for the treatment of Sporadic and Familial Nonampullary Nonpolypoid Duodenal Adenomas: C2D2 trial | $5,120 | 0 | 1 |
Payments by Medical Specialty
Top Paid Doctors
| Doctor | Specialty | Location | Total | 2022 |
|---|---|---|---|---|
| Unknown Provider | — | — | $155,100 | $0 |
| Klaus Mergener, M.d, M.D | Gastroenterology | Edmonds, WA | $153,311 | $0 |
| Dr. Pankaj Pasricha, Md, MD | Gastroenterology | Scottsdale, AZ | $100,084 | $0 |
| Craig Zalvan, Md, MD | Otolaryngology | Tarrytown, NY | $46,696 | $0 |
| Dr. Shelby Sullivan, Md, MD | Gastroenterology | Lebanon, NH | $37,647 | $0 |
| Dr. Vivek Kumbhari, Md, MD | Gastroenterology | Jacksonville, FL | $35,128 | $0 |
| Dr. Nirav Thosani, Md, MD | Gastroenterology | Houston, TX | $25,999 | $0 |
| Dr. Shyam Varadarajulu, Md, MD | Gastroenterology | St Petersburg, FL | $24,604 | $0 |
| Arvind Trindade, Md, MD | Gastroenterology | New Brunswick, NJ | $23,164 | $0 |
| Dr. Thomas Carroll, Md, MD | Otolaryngology | Boston, MA | $21,730 | $0 |
| Girish Mishra, Md, MD | Gastroenterology | Winston Salem, NC | $20,458 | $0 |
| Dr. Jeremy Barber, D.o, D.O | Internal Medicine | Grand Rapids, MI | $19,271 | $0 |
| Dr. Joseph Depietro, M.d, M.D | Otolaryngology | Yorktown Heights, NY | $18,020 | $0 |
| Dr. Sandeep Patel, Do, DO | Gastroenterology | San Antonio, TX | $17,391 | $0 |
| Mouen Khashab, Md, MD | Emergency Medicine | Baltimore, MD | $17,091 | $0 |
| Dr. Seth Gross, M.d, M.D | Gastroenterology | New York, NY | $16,961 | $0 |
| Amitabh Chak, Md, MD | Gastroenterology | Cleveland, OH | $15,186 | $0 |
| Manol Jovani, Md, Mph, MD, MPH | Gastroenterology | Miami, FL | $14,662 | $0 |
| Dr. Harshit Khara, M.d, M.D | Student in an Organized Health Care Education/Training Program | Danville, PA | $14,582 | $0 |
| David Diehl, M.d, M.D | Gastroenterology | Danville, PA | $13,590 | $0 |
| Roderick Warren, Md, MD | Family Medicine | Atchison, KS | $12,014 | $0 |
| Kalpesh Patel, Md, MD | Gastroenterology | Houston, TX | $11,977 | $0 |
| Bret Petersen, M.d, M.D | Gastroenterology | Rochester, MN | $10,488 | $0 |
| Dr. Deya Jourdy, M.d, M.D | Otolaryngology | Tarrytown, NY | $10,473 | $0 |
| John Evans, Md, MD | Gastroenterology | Winston Salem, NC | $9,762 | $0 |
Top Products
- C2 CryoBalloon $1.3M
- Cryoballoon $1.2M
Associated Products (18)
- C2 CryoBalloon $1.4M
- Cryoballoon $1.2M
- VIDEO DUODENOSCOPE $355,912
- DEC HD Duodenoscope $112,942
- OPTIVISTA $81,585
- VIDEO COLONOSCOPE $73,003
- ARIETTA $65,906
- VIDEO GASTROSCOPE $52,608
- PENTAX Medical $46,215
- INSPIRA $30,739
- Arietta $30,140
- Aloka Arietta 850 $28,462
- C.A.P. HD Duodenoscope $26,049
- NOBLUS $24,013
- C2 Cryoballoon $21,901
- VIDEO PROCESSOR $19,258
- IMAGINA $11,338
- SilkVoice $11,078
Payment Categories
- Food & Beverage $139,933
- Consulting $780,942
- Travel & Lodging $185,882
- Research $3.9M
About PENTAX of America, Inc.
PENTAX of America, Inc. has made $6.8M in payments to 1,204 healthcare providers, recorded across 3,837 transactions in the CMS Open Payments database. In 2024, the company paid $1.0M. The top product by payment volume is C2 CryoBalloon ($1.3M).
Payments were distributed across 58 medical specialties. The top specialty by payment amount is Gastroenterology ($718,120 to 607 doctors).
Payment categories include: Food & Beverage ($139,933), Consulting ($780,942), Research ($3.9M), Travel & Lodging ($185,882).
PENTAX of America, Inc. is associated with 18 products in the CMS Open Payments database, including C2 CryoBalloon, Cryoballoon, and VIDEO DUODENOSCOPE.